Renal actions of endothelin

Nord, Edward P.
August 1993
Kidney International;Aug1993, Vol. 44 Issue 2, p451
Academic Journal
Examines the mechanisms of action of endothelin (ET) in the kidney. Incrimination of ET in the pathophysiology of contrast-induced nephropathy; Identification of the endothelial cell as the prime synthesis site of the peptide and vascular smooth muscle cells as the target tissue; Consideration of the nature of the ET receptor present on different cellular structures within the kidney.


Related Articles

  • Vascular calcification in chronic kidney disease: not all arteries are created equal. Schlieper, Georg // Kidney International;Mar2014, Vol. 85 Issue 3, p501 

    Cardiovascular calcifications are associated with an increased cardiovascular risk. Different regions of the arterial tree show a variable susceptibility to cardiovascular calcification. O'Neill and Adams investigated breast arteries with vascular calcification in chronic kidney disease...

  • A case report of spontaneous rupture of a renal angiomyolipoma in a post-partum 21-year-old patient. Lucky, Marc A.; Shingler, Simon N.; Stephenson, Richard N. // Archives of Gynecology & Obstetrics;Oct2009, Vol. 280 Issue 4, p643 

    Renal angiomyolipomas (AML) are benign tumours containing vascular, smooth muscle and fatty elements. The majority of renal AML run an asymptomatic, benign course. The main associated complication is that of retro-peritoneal or intra-tumoural haemorrhage. Treatment options include conservative...

  • Direct, Acute Effects of Klotho and FGF23 on Vascular Smooth Muscle and Endothelium. Six, Isabelle; Okazaki, Hirokazu; Gross, Priscilla; Cagnard, Joanna; Boudot, Cédric; Maizel, Julien; Drueke, Tilman B.; Massy, Ziad A. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Chronic kidney disease (CKD) is regarded as a state of Klotho deficiency and FGF23 excess. In patients with CKD a strong association has been found between increased serum FGF23 and mortality risk, possibly via enhanced atherosclerosis, vascular stiffness, and vascular calcification. The aim of...

  • Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Karet, Fiona E.; Kuc, Rhoda E.; Davenport, Anthony P. // Kidney International;Jul1993, Vol. 44 Issue 1, p36 

    Endothelins (ET), a group of vasoconstrictor poptides, are expressed in a wide range of tissues and species and bind to specific receptors of which there are at least two subtypes, ETA and ETB. The kidney has been found in animal studies to be highly sensitive to the effects of ET. We have used...

  • Role of endothelin in the pathophysiology of renal ischemia- reperfusion in normal rabbits. Espinosa, Gaudencio; López# Farré, Antonio; Cernadas, María Rosa; Manzarbeitia, Felix; Tan, Dunyong; Digiuni, Enzo; Mosquera, Juan R.; Montón, Mercedes; Millás, Inmaculada; Hernando, Luis; Casado, Santos; Caramelo, Carlos // Kidney International;Sep1996, Vol. 50 Issue 3, p776 

    The present study addressed the acute effects of endothelin-1 on renal function and neutrophils accumulation in the setting of in vivo severe (60 min) acute ischemia/reperfusion. Ischemia/reperfusion decreased renal functional parameters and increased renal neutrophil accumulation and medullary...

  • Resistin: a newly identified chemokine for human CD4-positive lymphocytes. Walcher, Daniel; Hess, Katharina; Berger, Rebecca; Aleksic, Milos; Heinz, Philipp; Bach, Helga; Durst, Renate; Hausauer, Angelina; Hombach, Vinzenz; Marx, Nikolaus // Cardiovascular Research;Jan2010, Vol. 85 Issue 1, p167 

    Aims: Increased levels of resistin, a peptide secreted by adipocytes and inflammatory cells, circulate in patients with insulin resistance and early type 2 diabetes, a high-risk population for the development of a diffuse and extensive pattern of arteriosclerosis. Recent data suggest that...

  • Computational systems pharmacology and docking explored diosgenin targets causal and effectors pathogenic signalling network of vascular calcification. Manivannan, Jeganathan; Kumar, T. R. Barath; Arunagiri, Pandiyan; Balamurugan, Elumalai // Journal of Chemical & Pharmaceutical Research;2013, Vol. 5 Issue 1, p161 

    The Objective of this study is to investigate the multi-target potential of diosgenin on pathogenic network of vascular calcification due to the osteogenic transdifferentiation of vascular smooth muscle cell (VSMC). Target analysis of diosgenin was done via a 'reverse pharmacophore mapping' by...

  • 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Cardús, A.; Parisi, E.; Gallego, C.; Aldea, M.; Fernández, E.; Valdivielso, J. M. // Kidney International;Apr2006, Vol. 69 Issue 8, p1377 

    Atherosclerosis is a complex process characterized by an increase in the wall thickness owing to the accumulation of cells and extracellular matrix between the endothelium and the smooth muscle cell wall. This process is associated with different pathologies and it is accelerated in patients...

  • Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Scialla, Julia J; Lau, Wei Ling; Reilly, Muredach P; Isakova, Tamara; Yang, Hsueh-Ying; Crouthamel, Matthew H; Chavkin, Nicholas W; Rahman, Mahboob; Wahl, Patricia; Amaral, Ansel P; Hamano, Takayuki; Master, Stephen R; Nessel, Lisa; Chai, Boyang; Xie, Dawei; Kallem, Radhakrishna R; Chen, Jing; Lash, James P; Kusek, John W; Budoff, Matthew J // Kidney International;Jun2013, Vol. 83 Issue 6, p1159 

    Elevated fibroblast growth factor 23 (FGF23) is associated with cardiovascular disease in patients with chronic kidney disease. As a potential mediating mechanism, FGF23 induces left ventricular hypertrophy; however, its role in arterial calcification is less clear. In order to study this, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics